Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
In data we trust: how to nail consent and preference management
The pharmaceutical industry’s digital transformation during the pandemic has fuelled fresh opportunities to collect and harness data, but this venture must be approached with a strong consideration for consent and preference management rules
Amgen's Tamika Jean-Baptiste on creating an equitable experience
An interview with Tamika-Jean Baptiste, Vice President and Chief Diversity Officer, Amgen.
The value of purpose
The corporate environment is evolving, and ‘purpose’ is more important than ever to young recruits looking for their next role. We examine how the pharmaceutical industry is embracing the importance of purpose for retention, reputation, and brand differentiation
Sustainable solutions for a greener tomorrow
From drug development to disposal, how can all processes and functions be considered through a greener lens, and work towards a healthier and safer future?
The hard sell of cell and gene therapies
While the potential of cell and gene therapies (CGTs) is huge, the high cost raises concerns from payers. We explore how the industry can drive the adoption of CGTs to ensure that they reach patients around the world, rather than just those in private markets
Seeking solutions to low income low access
During the pandemic, low-to-middle-income countries (LMICs) have often been reliant on vaccine handouts from global initiatives and affluent nations. What are the emerging solutions that could improve access to vaccines in LMICs and self-sufficiency?
What is possible with preventative technology?
Tech giants have seized a huge share of the health and preventive technology market, but how could partnerships between the pharmaceutical and tech industries benefit patients and healthcare systems?
Clare Hague on drug pricing and market access
Clare Hague, Senior Director, Haematology Market Access, Europe, the Middle East, and Africa, Janssen, discusses drug pricing.
Julie Ross on International Equal Pay Day
Julie Ross, President, Advanced Clinical, talks about gender parity in the workplace in aid of International Equal Pay Day.
Carol Ross on corporate responsibility
Carol Lynch, Chief Business Officer, Sandoz, talks about how to increase the number of women in leadership positions in pharma and more.
←
1
2
3
…
14
15
16
17
18
19
20
21
22
→
We’ve noticed you’re accessing
from
North/South America.
View
View